...small seed fund. The seed fund’s size is not disclosed. Its investments included nanoparticle play Sitka Biopharma Inc....

...lateral sclerosis (ALS), raised C$1.8 million ($1.4 million) in a seed funding round. April 2016 Sitka Biopharma Inc....

...the commercialization vehicle for the non-profit Centre for Drug Research and Development, launched cancer company Sitka Biopharma...
...which is in preclinical testing for bladder cancer, was developed between CDRD and the university. Sitka Biopharma Inc....